Generation of four human induced pluripotent stem cell lines from COVID-19 hospitalized patients with increased levels of cardiac Troponin in the acute infection phase developing or not myocarditis

Coronavirus disease (COVID-19) is an infectious disease caused by SARS-CoV-2 virus, leading to mild to severe respiratory symptoms. Cardiovascular involvement is frequent and mainly manifests with myocarditis, arrhythmias, cardiac arrests, heart failure and coagulation abnormality. We generated huma...

Full description

Bibliographic Details
Main Authors: Martina Rabino, Erica Rurali, Chiara Zamboni, Davide Rovina, Sara Mallia, Matteo Cauteruccio, Andrea Baggiano, Carlo Maria Giacari, Milena Bellin, Giulio Pompilio
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Stem Cell Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1873506123000041
_version_ 1797897332591689728
author Martina Rabino
Erica Rurali
Chiara Zamboni
Davide Rovina
Sara Mallia
Matteo Cauteruccio
Andrea Baggiano
Carlo Maria Giacari
Milena Bellin
Giulio Pompilio
author_facet Martina Rabino
Erica Rurali
Chiara Zamboni
Davide Rovina
Sara Mallia
Matteo Cauteruccio
Andrea Baggiano
Carlo Maria Giacari
Milena Bellin
Giulio Pompilio
author_sort Martina Rabino
collection DOAJ
description Coronavirus disease (COVID-19) is an infectious disease caused by SARS-CoV-2 virus, leading to mild to severe respiratory symptoms. Cardiovascular involvement is frequent and mainly manifests with myocarditis, arrhythmias, cardiac arrests, heart failure and coagulation abnormality. We generated human induced pluripotent stem cells (hiPSCs) from four COVID-19 patients, all characterized by increased levels of high-sensitivity Troponin I (hsTnI) during the infection acute phase, who developed (n = 2) or not (n = 2) severe myocarditis, as COVID-19 complication. The established hiPSCs were characterized for pluripotency and genomic stability, and constitute a useful resource for studying the mechanisms underlying the variability in COVID-19 severe cardiac manifestations.
first_indexed 2024-04-10T07:55:51Z
format Article
id doaj.art-e333f93aa82d4a948b10776b34e1ee80
institution Directory Open Access Journal
issn 1873-5061
language English
last_indexed 2024-04-10T07:55:51Z
publishDate 2023-03-01
publisher Elsevier
record_format Article
series Stem Cell Research
spelling doaj.art-e333f93aa82d4a948b10776b34e1ee802023-02-23T04:30:51ZengElsevierStem Cell Research1873-50612023-03-0167103018Generation of four human induced pluripotent stem cell lines from COVID-19 hospitalized patients with increased levels of cardiac Troponin in the acute infection phase developing or not myocarditisMartina Rabino0Erica Rurali1Chiara Zamboni2Davide Rovina3Sara Mallia4Matteo Cauteruccio5Andrea Baggiano6Carlo Maria Giacari7Milena Bellin8Giulio Pompilio9Unit of Vascular Biology and Regenerative Medicine, Centro Cardiologico Monzino IRCCS, Milan, Italy; Corresponding author at: Unit of Vascular Biology and Regenerative Medicine, Centro Cardiologico Monzino IRCCS, Milan, Italy.Unit of Vascular Biology and Regenerative Medicine, Centro Cardiologico Monzino IRCCS, Milan, ItalyUnit of Vascular Biology and Regenerative Medicine, Centro Cardiologico Monzino IRCCS, Milan, ItalyUnit of Vascular Biology and Regenerative Medicine, Centro Cardiologico Monzino IRCCS, Milan, ItalyUnit of Vascular Biology and Regenerative Medicine, Centro Cardiologico Monzino IRCCS, Milan, ItalyUnit of Vascular Biology and Regenerative Medicine, Centro Cardiologico Monzino IRCCS, Milan, ItalyPeri Operative Cardiology and Cardiovascular Imaging Department, Centro Cardiologico Monzino IRCCS, Milan, Italy; Dipartimento di Scienze Cliniche e di Comunità, Università degli Studi di Milano, Milan, ItalyPeri Operative Cardiology and Cardiovascular Imaging Department, Centro Cardiologico Monzino IRCCS, Milan, ItalyDepartment of Biology, University of Padova, Padova, Italy; Veneto Institute of Molecular Medicine, Padova, Italy; Departmant of Anatomy and Embryology, Leiden University Medical Center, Leiden, the NetherlandsUnit of Vascular Biology and Regenerative Medicine, Centro Cardiologico Monzino IRCCS, Milan, Italy; Dipartimento di Scienze Biomediche, Chirurgiche ed Odontoiatriche, Università degli Studi di Milano, Milan, ItalyCoronavirus disease (COVID-19) is an infectious disease caused by SARS-CoV-2 virus, leading to mild to severe respiratory symptoms. Cardiovascular involvement is frequent and mainly manifests with myocarditis, arrhythmias, cardiac arrests, heart failure and coagulation abnormality. We generated human induced pluripotent stem cells (hiPSCs) from four COVID-19 patients, all characterized by increased levels of high-sensitivity Troponin I (hsTnI) during the infection acute phase, who developed (n = 2) or not (n = 2) severe myocarditis, as COVID-19 complication. The established hiPSCs were characterized for pluripotency and genomic stability, and constitute a useful resource for studying the mechanisms underlying the variability in COVID-19 severe cardiac manifestations.http://www.sciencedirect.com/science/article/pii/S1873506123000041
spellingShingle Martina Rabino
Erica Rurali
Chiara Zamboni
Davide Rovina
Sara Mallia
Matteo Cauteruccio
Andrea Baggiano
Carlo Maria Giacari
Milena Bellin
Giulio Pompilio
Generation of four human induced pluripotent stem cell lines from COVID-19 hospitalized patients with increased levels of cardiac Troponin in the acute infection phase developing or not myocarditis
Stem Cell Research
title Generation of four human induced pluripotent stem cell lines from COVID-19 hospitalized patients with increased levels of cardiac Troponin in the acute infection phase developing or not myocarditis
title_full Generation of four human induced pluripotent stem cell lines from COVID-19 hospitalized patients with increased levels of cardiac Troponin in the acute infection phase developing or not myocarditis
title_fullStr Generation of four human induced pluripotent stem cell lines from COVID-19 hospitalized patients with increased levels of cardiac Troponin in the acute infection phase developing or not myocarditis
title_full_unstemmed Generation of four human induced pluripotent stem cell lines from COVID-19 hospitalized patients with increased levels of cardiac Troponin in the acute infection phase developing or not myocarditis
title_short Generation of four human induced pluripotent stem cell lines from COVID-19 hospitalized patients with increased levels of cardiac Troponin in the acute infection phase developing or not myocarditis
title_sort generation of four human induced pluripotent stem cell lines from covid 19 hospitalized patients with increased levels of cardiac troponin in the acute infection phase developing or not myocarditis
url http://www.sciencedirect.com/science/article/pii/S1873506123000041
work_keys_str_mv AT martinarabino generationoffourhumaninducedpluripotentstemcelllinesfromcovid19hospitalizedpatientswithincreasedlevelsofcardiactroponinintheacuteinfectionphasedevelopingornotmyocarditis
AT ericarurali generationoffourhumaninducedpluripotentstemcelllinesfromcovid19hospitalizedpatientswithincreasedlevelsofcardiactroponinintheacuteinfectionphasedevelopingornotmyocarditis
AT chiarazamboni generationoffourhumaninducedpluripotentstemcelllinesfromcovid19hospitalizedpatientswithincreasedlevelsofcardiactroponinintheacuteinfectionphasedevelopingornotmyocarditis
AT daviderovina generationoffourhumaninducedpluripotentstemcelllinesfromcovid19hospitalizedpatientswithincreasedlevelsofcardiactroponinintheacuteinfectionphasedevelopingornotmyocarditis
AT saramallia generationoffourhumaninducedpluripotentstemcelllinesfromcovid19hospitalizedpatientswithincreasedlevelsofcardiactroponinintheacuteinfectionphasedevelopingornotmyocarditis
AT matteocauteruccio generationoffourhumaninducedpluripotentstemcelllinesfromcovid19hospitalizedpatientswithincreasedlevelsofcardiactroponinintheacuteinfectionphasedevelopingornotmyocarditis
AT andreabaggiano generationoffourhumaninducedpluripotentstemcelllinesfromcovid19hospitalizedpatientswithincreasedlevelsofcardiactroponinintheacuteinfectionphasedevelopingornotmyocarditis
AT carlomariagiacari generationoffourhumaninducedpluripotentstemcelllinesfromcovid19hospitalizedpatientswithincreasedlevelsofcardiactroponinintheacuteinfectionphasedevelopingornotmyocarditis
AT milenabellin generationoffourhumaninducedpluripotentstemcelllinesfromcovid19hospitalizedpatientswithincreasedlevelsofcardiactroponinintheacuteinfectionphasedevelopingornotmyocarditis
AT giuliopompilio generationoffourhumaninducedpluripotentstemcelllinesfromcovid19hospitalizedpatientswithincreasedlevelsofcardiactroponinintheacuteinfectionphasedevelopingornotmyocarditis